IL13Rα2 D1

CAT:
804-HY-P11147
Size:
1 Each
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
IL13Rα2 D1 - image 1

IL13Rα2 D1

  • Description:

    IL13Rα2 D1 is an effective IL-13/IL13Rα2 signaling axis inhibitor. IL13Rα2 D1 can inhibit IL-13-induced cell adhesion, migration, invasion, and proliferation. IL13Rα2 D1 can inhibit FAK, Src, AKT, ERK1/2 phosphorylation, and MMP expression. IL13Rα2 D1 can be used for research on cancers such as colorectal cancer[1].
  • UNSPSC:

    12352209
  • Target:

    Akt; ERK; FAK; Interleukin Related; MMP; Src
  • Related Pathways:

    Immunology/Inflammation; MAPK/ERK Pathway; Metabolic Enzyme/Protease; PI3K/Akt/mTOR; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
  • Field of Research:

    Cancer
  • Smiles:

    O=C (N[C@@H] (CO) C (N[C@@H] (CCC (O) =O) C (N[C@@H] ([C@H] (O) C) C (N[C@@H] (CC1=CNC2=CC=CC=C12) C (N[C@@H] (CCCCN) C (N[C@@H] ([C@H] (O) C) C (N[C@@H] ([C@@H] (C) CC) C (N[C@@H] ([C@@H] (C) CC) C (N[C@@H] ([C@H] (O) C) C (N[C@@H] (CCCCN) C (N[C@@H] (CC (N) =O) C (O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) =O) CN
  • Molecular Formula:

    C61H100N16O20
  • Molecular Weight:

    1377.54
  • References & Citations:

    [1]Bartolomé RA, et al. An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer. Br J Cancer. 2018 Oct;119 (8) :940-949.
  • Shipping Conditions:

    Room temperature
  • Scientific Category:

    Peptides
  • Clinical Information:

    No Development Reported
  • Isoform:

    IL-13
  • CAS Number:

    2319573-67-4